Atlas FDA

VNS THERAPY SYSTEM

FDA premarket approval P970003/S078 · decided 2007-04-12

Approval details

PMA number
P970003
Supplement
S078
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2007-03-27
Decision date
2007-04-12
Days to decision
16 days
Decision code
APPR
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
APPROVAL FOR THE ADDITION OF DETAILED INFORMATION CONTAINED IN THE APPROVED TEST TO THE FIGURES PROVIDED IN THE LABELING TO PROVIDE FURTHER CLARIFICATION CONCERNING THE PROPER LEAD IMPLANT TECHNIQUE. ADDITIONALLY, FURTHER DETAILS WERE PROVIDED TO STRESS THE IMPORTANCE OF PROPER STRAIN RELIEF PLACEMENT (I.E. PROPER TIE-DOWN LOCATION AND STRAIN RELIEF BEND).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08